Cerebral microbleed detection and mapping: principles, methodological aspects and rationale in vascular dementia

Area of Science:

• Neurology
• Radiology
• Geriatrics

Background:

• Cerebral microbleeds (CMBs) are key imaging markers of cerebral small vessel diseases, particularly hypertensive arteriopathy and cerebral amyloid angiopathy.
• These conditions are common in the elderly and significantly contribute to vascular cognitive impairment and dementia.
• Advanced MRI techniques like T2*-GRE and SWI enhance CMB detection, revealing their prevalence in both patient and healthy elderly populations.

Purpose of the Study:

• To address clinical and pathophysiological questions regarding the mechanisms, diagnosis, and monitoring of cognitive impairment related to CMBs.
• To emphasize the importance of reliable detection, definition, and mapping of CMBs in the aging brain.
• To review current methodologies for CMB identification and discuss future automated approaches.

Main Methods:

• Review of radiological detection methods for cerebral microbleeds.
• Discussion of criteria for defining CMBs, including identification of mimics.
• Consideration of standardized rating scales for CMB assessment.

Main Results:

• CMBs are increasingly detected in elderly populations, including those with cognitive impairment and healthy individuals.
• Advanced MRI techniques have significantly improved the ability to visualize CMBs.
• The review consolidates approaches to CMB detection and definition.

Conclusions:

• Reliable detection and mapping of CMBs are essential for understanding their impact on cognitive function and small vessel diseases.
• Standardized methods and future automated tools are needed for accurate CMB assessment.
• Further research is warranted to elucidate the full clinical significance of CMBs in aging.